# Tolerability of Grazax-R in Children

> **NCT00298701** · PHASE1 · COMPLETED · sponsor: **ALK-Abelló A/S** · enrollment: 50 (—)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** ALK Grass tablet

## Key facts

- **NCT ID:** NCT00298701
- **Lead sponsor:** ALK-Abelló A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 50 (—)
- **Last updated:** 2006-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298701, "Tolerability of Grazax-R in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00298701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*